MyoKardia, Inc. Common Stock
MYOK
MYOK was delisted on the 16th of November, 2020.
115 hedge funds and large institutions have $974M invested in MyoKardia, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 49 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 9 closing their positions.
444% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 9
371% more capital invested
Capital invested by funds: $207M → $974M (+$767M)
81% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 21
53% more funds holding
Funds holding: 75 → 115 (+40)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$34.6M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
+$22M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.6M |
| 4 |
D.E. Shaw & Co
New York
|
+$18.8M |
| 5 |
BlackRock
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.1M |
| 2 |
JP Morgan Chase
New York
|
-$10M |
| 3 |
Millennium Management
New York
|
-$7.12M |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$4.46M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$2.75M |
MYOK Hedge Fund Activity: Q3 2017 in Review
115 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q3 2017, worth a combined $974M — up 371% from $207M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new MYOK positions and 9 closed out — a net gain of 40 holders — while 38 added to existing stakes and 21 trimmed.
The largest buyer was Deerfield Management, adding an estimated $34.6M. The largest seller was Fidelity Investments, cutting an estimated $16.1M.
- 115 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q3 2017, up from 75 in Q2 2017.
- Funds reported $974M of MyoKardia, Inc. Common Stock stock for Q3 2017, up 371% quarter-over-quarter.
- 49 funds opened new MyoKardia, Inc. Common Stock positions in Q3 2017 and 9 closed out, a net change of +40 holders.
- The largest MyoKardia, Inc. Common Stock buyer in Q3 2017 was Deerfield Management, an estimated $34.6M added.
- The largest MyoKardia, Inc. Common Stock seller in Q3 2017 was Fidelity Investments, an estimated $16.1M sold.
Based on aggregated 13F filings for Q3 2017.